Drug Trial Radar · NCT02149199
A Clinical Study to Evaluate Symbicort Turbuhaler Used 'as Needed' in Adults and Adolescents With Asthma.
Last checked: Nov 19, 2026Latest source record: Nov 15, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,850
Actual
Start
Jul 7, 2014
Primary completion
Aug 2, 2017
Study completion Aug 2, 2017
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- May 29, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years, up to 130 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to test if Symbicort® (budesonide/formoterol) Turbuhaler® is effective in treating asthma when used 'as needed' in patients with milder asthma. The efficacy of Symbicort® 'as needed' will be compared with: 1) terbutaline Turbuhaler® 'as needed' and with 2) Pulmicort (budesonide) Turbuhaler® twice daily plus terbutaline Turbuhaler® 'as needed'.
Conditions
- Asthma
Interventions
budesonide/formoterol 'as needed' + budesonide placebo bidDrug
Symbicort (budesonide/ formoterol) 160/4.5 μg powder for inhalation 'as needed' plus Pulmicort placebo 200 μg powder for inhalation, 1 inhalation twice daily (morning and evening), 52-week treatment
terbutaline 'as needed' + placebo budesonide bidDrug
Terbutaline 0.4 mg powder for inhalation 'as needed' plus placebo Pulmicort (budesonide) 200 μg powder for inhalation, 1 inhalation twice daily (morning and evening), 52-week treatment
budesonide bid + terbutaline 'as needed'Drug
Pulmicort (budesonide) 200 μg powder for inhalation, 1 inhalation twice daily (morning and evening) plus terbutaline 0.4 mg powder for inhalation 'as needed', 52-week treatment
Primary outcomes
What the sponsor says the trial is designed to measure.
- 'Well-controlled Asthma Week' - a Derived Binary Variable (Yes/No)Time frame: Weekly, up to 52 weeks
Locations
255 sites in 18 countries. Site status is shown where the registry gives one.
Research Site
Bedford Park, Australia
Research Site
Concord, Australia
Research Site
Maroubra, Australia
Research Site
Murdoch, Australia
Research Site
Wollongong, Australia
Research Site
Alphaville, Brazil
Research Site
Botucatu, Brazil
Research Site
Porto Alegre, Brazil
Research Site
Porto Alegre, Brazil
Research Site
Porto Alegre, Brazil
Research Site
Salvador, Brazil
Research Site
Santo André, Brazil
Research Site
São Paulo, Brazil
Research Site
São Paulo, Brazil
Research Site
Sorocaba, Brazil
Research Site
Dupnitsa, Bulgaria
Research Site
Gotse Delchev, Bulgaria
Research Site
Kozloduy, Bulgaria
Research Site
Pazardzhik, Bulgaria
Research Site
Plovdiv, Bulgaria
Research Site
Razgrad, Bulgaria
Research Site
Roman, Bulgaria
Research Site
Rousse, Bulgaria
Research Site
Sandanski, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Varna, Bulgaria
Research Site
Velingrad, Bulgaria
Research Site
Vratsa, Bulgaria
Research Site
Edmonton, Alberta, Canada
Research Site
Sherwood Park, Alberta, Canada
Research Site
Maple Ridge, British Columbia, Canada
Research Site
North Vancouver, British Columbia, Canada
Research Site
Vancouver, British Columbia, Canada
Research Site
Mount Pearl, Newfoundland and Labrador, Canada
Research Site
St. John's, Newfoundland and Labrador, Canada
Research Site
Ajax, Ontario, Canada
Showing 40 of 255 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.